DISCUSSION Melanotic Neuroectodermal Tumor of Infancy (MNTI), first described in 1918 by Krompecher, reporting 215 cases since 1992, is a rare, pigmented, benign, locally aggressive, recurrent, and possibly malignant neoplasm with metastatic capacity
By supplementing B-12 levels through MIC/B-12 injections, individuals may experience increased energy levels and reduced fatigue
Continuous MT-1 administration beyond 3 weeks causes receptor desensitization, where melanocytes downregulate MC1R surface expression in response to sustained agonist binding
NAD+ Injection Benefits Boosts Cellular Energy: Reduces chronic fatigue and enhances endurance
Also, data analysis showed that the serum GLP-1 level of patients with newly diagnosed T2DM combined with CAS was significantly reduced compared with the control group
Treatment Overview Glutathione is the body's "master antioxidant," a tripeptide made from glutamine, glycine, and cysteine